TP53 and cancer: Four KEGG signaling pathways were identified as enriched (Benjamini and Hochberg39 adjusted p-value < 0.05), including Hematopoietic cell lineage, Cell cycle, p53 signaling pathway, and Transcriptional misregulation in cancer.